UNSPSC 51172810: Benzocaine/chlorobutanol/eugenol/peruvian balsam

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR900. This VA Drug Class (OR900) classifies this compound as belonging to the group DENTAL AND ORAL AGENTS, TOPICAL, OTHER.

UNSPSC 51172810 Benzocaine/chlorobutanol/eugenol/peruvian balsam is a Commodity code covering specific pharmaceutical active ingredients used in topical analgesic and antiseptic formulations, though state and local procurement activity under this code focuses on broader generic multi-source pharmaceuticals and over-the-counter products distributed through established wholesale channels rather than discrete ingredient procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body surfacing in recent activity, soliciting manufacturers to supply comprehensive pharmaceutical inventories to participating state and local government facilities across multiple jurisdictions including Oregon. Vendors supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain contractual relationships with at least two of the three wholesalers with chargeback systems in place, and carry comprehensive insurance including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability.

The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 for Generic Multi Source Pharmaceuticals and OTC Products on January 20, 2026, with proposals due March 26, 2026, a cutoff date for questions on February 18, 2026, and award effective July 1, 2026. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and 5 percent each on compliance with administrative fee data format requirements, EDI capability, and agreement to a 3 percent administrative fee. The contract term runs two years for new responders with optional extensions at MMCAP's discretion, while incumbent responder amendments align with existing agreement expiration dates through June 30, 2028. All products must be available in the marketplace by May 15, 2026, possess FDA approval, carry expiration dates of at least one year from manufacture with minimum six-month shelf life, and vendors must submit detailed product information including NDC codes, SKUs, UPCs, generic descriptions, strength, dosage form, and manufacturing locations through the ePro procurement system using designated Excel spreadsheet format converted to CSV.